Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideUNHUnitedHealth Group
FinDog View：Neutral
VRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | UNH | VRTX |
|---|
| Close | 375.26 | 513.26 |
| Market Cap | $337B | $121B |
| 1M | −5.15% | −0.44% |
| P/E (TTM) | 23.9 | 29.7 |
| Forward P/E | 19.7 | 24.0 |
| P/E 5-Yr Percentile | 53 | 52 |
| P/S | 0.8 | 10.4 |
| P/B | 3.2 | 6.5 |
| Dividend Yield | 1.37% | — |
| Latest Quarter Revenue | $112B | $3.3B |
| Revenue YoY | +0.4% | +12.5% |
| Gross Margin | 88.1% | 85.3% |
| Latest Quarter EPS | 6.04 | 4.31 |
| Avg Post-Earnings Move | ±3.1% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.89% | 1.66% |
| 90-Day Net Insider Buying | −$0.66M | −$2.8M |
UNH · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
